Journal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 75, Issue 18, Pages 2309-2311Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2020.03.037
Keywords
acute coronary syndromes; alirocumab; cholesterol; cost-effectiveness; economic analysis